BSE Live
Jan 09, 09:47Prev. Close
163.95
Open Price
164.25
Bid Price (Qty.)
164.90 (24)
Offer Price (Qty.)
166.15 (30)
NSE Live
Jan 09, 09:48Prev. Close
164.17
Open Price
165.40
Bid Price (Qty.)
165.22 (99)
Offer Price (Qty.)
165.70 (33)
| Balance Sheet of Suven Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 21.81 | 21.81 | 21.81 | 14.54 | 12.73 | |
| Total Share Capital | 21.81 | 21.81 | 21.81 | 14.54 | 12.73 | |
| Reserves and Surplus | 777.70 | 823.57 | 831.64 | 461.44 | 352.01 | |
| Total Reserves and Surplus | 777.70 | 823.57 | 831.64 | 461.44 | 352.01 | |
| Total Shareholders Funds | 799.51 | 845.38 | 853.44 | 475.98 | 401.65 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.39 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.58 | 1.57 | 2.38 | |
| Long Term Provisions | 1.71 | 1.35 | 1.88 | 2.00 | 1.73 | |
| Total Non-Current Liabilities | 1.71 | 1.35 | 2.46 | 3.57 | 4.50 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.48 | 0.00 | |
| Trade Payables | 5.23 | 2.07 | 1.66 | 1.99 | 3.00 | |
| Other Current Liabilities | 0.80 | 1.58 | 1.84 | 3.44 | 5.45 | |
| Short Term Provisions | 1.64 | 1.12 | 1.03 | 0.89 | 0.78 | |
| Total Current Liabilities | 7.67 | 4.76 | 4.54 | 6.80 | 9.23 | |
| Total Capital And Liabilities | 808.89 | 851.48 | 860.44 | 486.35 | 415.39 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 59.47 | 28.01 | 37.02 | 37.34 | 17.74 | |
| Intangible Assets | 0.18 | 0.20 | 0.20 | 0.22 | 3.22 | |
| Capital Work-In-Progress | 0.01 | 0.00 | 0.00 | 3.55 | 4.77 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 59.66 | 28.21 | 37.21 | 41.12 | 25.74 | |
| Non-Current Investments | 691.47 | 577.11 | 481.86 | 380.69 | 295.03 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.05 | 0.02 | 100.11 | 0.33 | 0.00 | |
| Total Non-Current Assets | 751.18 | 605.34 | 619.18 | 422.13 | 320.76 | |
| CURRENT ASSETS | ||||||
| Current Investments | 22.28 | 75.94 | 46.34 | 45.16 | 0.09 | |
| Inventories | 0.24 | 0.71 | 0.00 | 0.02 | 0.14 | |
| Trade Receivables | 1.34 | 1.29 | 0.81 | 1.30 | 1.76 | |
| Cash And Cash Equivalents | 19.96 | 153.45 | 173.96 | 3.15 | 38.59 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 41.45 | |
| OtherCurrentAssets | 13.89 | 14.76 | 20.16 | 14.59 | 12.59 | |
| Total Current Assets | 57.71 | 246.14 | 241.26 | 64.22 | 94.62 | |
| Total Assets | 808.89 | 851.48 | 860.44 | 486.35 | 415.39 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 6.17 | 4.28 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 131.89 | 104.42 | 113.70 | 110.58 | 73.74 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | 9.31 | |
| Other Earnings | 2.23 | 8.75 | 5.48 | 5.30 | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.76 | 5.76 | 5.76 | 5.76 | 5.76 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 691.47 | 577.11 | 481.86 | 380.69 | 295.03 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 22.28 | 75.94 | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | 46.34 | 45.16 | 0.09 |
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y
17.11.2025
Suven Life Sci Consolidated September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
12.11.2025
Suven Life Sci Standalone September 2025 Net Sales at Rs 0.92 crore, down 64.27% Y-o-Y
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y